FEBS Letters
Volume 580, Issue 23 , Pages 5533-5540, 9 October 2006

Drug-induced phospholipidosis

Edited by Gerrit van Meer

  • Nora Anderson

      Affiliations

    • Medical School of Hannover, Center for Pharmacology and Toxicology, Carl-Neuberg-Straße 1, 30625 Hannover, Germany
  • ,
  • Jürgen Borlak

      Affiliations

    • Medical School of Hannover, Center for Pharmacology and Toxicology, Carl-Neuberg-Straße 1, 30625 Hannover, Germany
    • Fraunhofer Institute of Toxicology and Experimental Medicine, Nikolai-Fuchs-Str. 1, 30625 Hannover, Germany
    • Corresponding Author InformationCorresponding author. Address: Fraunhofer Institute of Toxicology and Experimental Medicine, Nikolai-Fuchs-Str. 1, 30625 Hannover, Germany.

Received 9 June 2006; received in revised form 3 July 2006; accepted 25 August 2006. published online 04 September 2006.

Abstract 

Drug-induced phospholipidosis is characterized by intracellular accumulation of phospholipids with lamellar bodies, most likely from an impaired phospholipid metabolism of the lysosome. Organs affected by phospholipidosis exhibit inflammatory reactions and histopathological changes. Despite significant advances in the understanding of drug-altered lipid metabolism, the relationship between impaired phospholipid metabolism and drug-induced toxicity remains enigmatic. Here we review molecular features of inheritable lysosomal storage disorders as a molecular mimicry of drug-induced phospholipidosis for an improved understanding of adverse drug reaction.

Keywords: Drug-induced phospholipidosis, Lysosome, Cationic amphiphilic drug, Lamellar body

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0014-5793(06)01032-5

doi:10.1016/j.febslet.2006.08.061

FEBS Letters
Volume 580, Issue 23 , Pages 5533-5540, 9 October 2006